Effect of topical honey application along with intralesional injection of glucantime in the treatment of the cutaneous leishmaniasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12004149

Enrollment

100

Registered

2006-11-13

Start date

2004-12-21

Completion date

Unknown

Last updated

2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis Infections and Infestations Leishmaniasis

Interventions

Topical honey along with intralesional glucantime versus intralesional glucantime alone.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed cutaneous leishmaniasis with direct smear 2. No history of systemic or topical therapy for cutaneous leishmaniasis 3. Absence of the malnutrition or severe predisposing disease such as cardiac, renal or hepatic disease and other contraindication for glucantime

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Curing of the leishmaiasis	—

Secondary

Measure	Time frame
Diameter of the lesion and size of the erythema, induration and ulcer	—

Countries

Iran

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026